AAAAAA

   
Results: 1-8 |
Results: 8
Cholesterol catabolism in patients with acute myelogenous leukemia and hypocholesterolemia: suppressed levels of a circulating marker for bile acid synthesis
Authors: Tatidis, L Vitols, S Gruber, A Paul, C Axelson, M
Citation: L. Tatidis et al., Cholesterol catabolism in patients with acute myelogenous leukemia and hypocholesterolemia: suppressed levels of a circulating marker for bile acid synthesis, CANCER LETT, 170(2), 2001, pp. 169-175
Effects of treatment with deoxycholic acid and chenodeoxycholic acid on the hepatic synthesis of cholesterol and bile acids in healthy subjects
Authors: Einarsson, C Hillebrant, CG Axelson, M
Citation: C. Einarsson et al., Effects of treatment with deoxycholic acid and chenodeoxycholic acid on the hepatic synthesis of cholesterol and bile acids in healthy subjects, HEPATOLOGY, 33(5), 2001, pp. 1189-1193
Defective 11 beta-HSD reductase activity in a patient with congenital adrenal hyperplasia
Authors: Nordenstrom, A Marcus, C Axelson, M Wedell, A Ritzen, M
Citation: A. Nordenstrom et al., Defective 11 beta-HSD reductase activity in a patient with congenital adrenal hyperplasia, J CLIN END, 86(3), 2001, pp. 1426-1427
Endocrine effects of the podophyllotoxine derivative drug CPH 82 (Reumacon(R)) in patients with rheumatoid arthritis
Authors: Carlstrom, K Hedin, PJ Jonsson, L Lerndal, T Lien, J Weitoft, T Axelson, M
Citation: K. Carlstrom et al., Endocrine effects of the podophyllotoxine derivative drug CPH 82 (Reumacon(R)) in patients with rheumatoid arthritis, SC J RHEUM, 29(2), 2000, pp. 89-94
Bile acid synthesis in cultured human hepatocytes: Support for an alternative biosynthetic pathway to cholic acid
Authors: Axelson, M Ellis, E Mork, B Garmark, K Abrahamsson, A Bjorkhem, I Ericzon, BG Einarsson, C
Citation: M. Axelson et al., Bile acid synthesis in cultured human hepatocytes: Support for an alternative biosynthetic pathway to cholic acid, HEPATOLOGY, 31(6), 2000, pp. 1305-1312
Deoxycholic acid treatment in patients with cholesterol gallstones: failure to detect a suppression of cholesterol 7 alpha-hydroxylase activity
Authors: Hillebrant, CG Nyberg, B Angelin, B Axelson, M Bjorkhem, I Rudling, M Einarsson, C
Citation: Cg. Hillebrant et al., Deoxycholic acid treatment in patients with cholesterol gallstones: failure to detect a suppression of cholesterol 7 alpha-hydroxylase activity, J INTERN M, 246(4), 1999, pp. 399-407
Failure of cortisone acetate treatment in congenital adrenal hyperplasia because of defective 11 beta-hydroxysteroid dehydrogenase reductase activity
Authors: Nordenstrom, A Marcus, C Axelson, M Wedell, A Ritzen, EM
Citation: A. Nordenstrom et al., Failure of cortisone acetate treatment in congenital adrenal hyperplasia because of defective 11 beta-hydroxysteroid dehydrogenase reductase activity, J CLIN END, 84(4), 1999, pp. 1210-1213
Effect of inhibiting HMG-CoA reductase on 7 alpha-hydroxy-4-cholesten-3-one, a marker of bile acid synthesis: contrasting findings in patients with and without prior up-regulation of the latter pathway
Authors: Naoumova, RP O'Neill, FH Dunn, S Neuwirth, CKY Taylor, GW Axelson, M Thompson, GR
Citation: Rp. Naoumova et al., Effect of inhibiting HMG-CoA reductase on 7 alpha-hydroxy-4-cholesten-3-one, a marker of bile acid synthesis: contrasting findings in patients with and without prior up-regulation of the latter pathway, EUR J CL IN, 29(5), 1999, pp. 404-412
Risultati: 1-8 |